Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Insider Filings - ROWINSKY ERIC K
Last Updated 
15-Jun-15
Enter symbol:
symbol lookup

 

EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search

ROWINSKY ERIC K: Declared Holdings
Company/RelationshipReportedShares  Ownership
Biogen Idec Inc.
Director
NasdaqGS:BIIB
(historical quotes, profile, other insiders)
10-Jun-1512,005  Direct
Navidea Biopharmaceuticals, Inc
Director
NYSE MKT:NAVB
(historical quotes, profile, other insiders)
26-Mar-15185,720  Direct

Insider & restricted shareholder transactions reported over the last two years
DateSharesStockTransaction
10-Jun-15 695BIIB Acquisition (Non Open Market) at $0 per share.
26-Mar-15 22,000NAVB Acquisition (Non Open Market) at $0 per share.
20-Mar-15 11,667BIIB Automatic Sale at $475 per share.
(Proceeds of $5,541,825)
20-Mar-15 11,667BIIB Option Exercise at $59.82 per share.
(Cost of $697,919)
19-Mar-15 2,333BIIB Automatic Sale at $436.14 per share.
(Proceeds of $1,017,514)
19-Mar-15 2,333BIIB Option Exercise at $59.82 per share.
(Cost of $139,560)
17-Mar-15 4,667BIIB Automatic Sale at $425.45 per share.
(Proceeds of $1,985,575)
17-Mar-15 4,667BIIB Option Exercise at $59.82 per share.
(Cost of $279,179)
9-Mar-15 4,666BIIB Automatic Sale at $417.23 per share.
(Proceeds of $1,946,795)
9-Mar-15 4,666BIIB Option Exercise at $59.82 per share.
(Cost of $279,120)
10-Nov-14 9,470NAVB Acquisition (Non Open Market) at $1.32 per share.
(Value of $12,500)
12-Jun-14 870BIIB Acquisition (Non Open Market) at $0 per share.
13-Feb-14 20,000NAVB Acquisition (Non Open Market) at $0 per share.
21-Jan-14 2,020BIIB Automatic Sale at $310.09 per share.
(Proceeds of $626,381)


EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search


Copyright © 2015 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Data and information are provided by EDGAR Online, Inc. for informational purposes only and not intended for trading purposes. Yahoo!, EDGAR Online, Inc. shall have no liability for the accuracy of the information furnished or for delays, omissions or opinions expressed therein. You may not use the information for any illegal purpose or furnish the information to any person, firm, or branch office for commercial re-use or re-sale.

Questions or Comments?